PMC6993817_01
Clinical presentation before cetuximab (
a) and after six (
b) and 12 weeks of therapy (
c).
f1000research-8-23781-g0000.jpg
PMC6993817_01_f1000research-8-23781-g0000.jpg
f1
The patient reported intermittent pain and bleeding ( Figure 1).
CT scan performed at baseline (
a), after six (
b) and 12 weeks of therapy (
c), highlighting the anterior-posterior diameter of the tumor.
f1000research-8-23781-g0001.jpg
PMC6993817_01_f1000research-8-23781-g0001.jpg
f2
A stage III-disease (T3N0M0, Figure 2a)  advised the use of anti-PD-1 therapy. Follow-up assessment with periodic CT at three ( Figure 2b and 2c) and six months documented stable locally advanced disease.